The Pharmaceutical Journal
Vol 275 No 7378 p680
3 December 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Calprofen reclassification

Pfizer Consumer Healthcare has applied to the Medicines and Healthcare products Regulatory Agency to have Calprofen 100mg/5ml oral suspension (ibuprofen) reclassified as a general sale list medicine.